‘The best thing that you can do for your career is to make yourself redundant’: Inside Stellantis’ AI push after the ‘starting gun went off’ Nebex CEO: NASA wants a commercial space economy. Here’s how it can enable one Ukraine is pushing fiber-optic drones to greater ranges. One maker questions whether that's worth the trade-offs. Canceled port calls and cash appeals: Inside the final months of the Villa Vie Odyssey's doomed round-the-world cruise A retired student-loan borrower is fighting for public service debt relief. Now he's named in a lawsuit against Trump. I run an 8-person startup that uses AI agents. We don't let our agents run on vibes — here's the playbook system we created Markets podcaster Ed Elson says investors are reading Anthropic's S-1 wrong What a veteran bond investor is watching as sharp interest rate moves roil markets This new indie film about an AI startup founder and his family feels less like sci-fi by the day OpenAI pares fundraising goal, now seeking up to $20 billion in latest round

Hu Kaijun

Hu Kaijun

Hu Kaijun (#1492)

Global Rank #1492
Country Rank #170
Country China

Hu Kaijun is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 3 B
  • Pharmaceuticals
  • China
  • M
  • 64 Years

Snapshot

Quick Facts

Global Rank #1,492
Country Rank #170
Net Worth $2.8B
Previous Worth $2.8B
Worth Change +$0.0B
Country China
Industry Pharmaceuticals
Age 64 Years
Gender M
Worth As Of May 4, 2026
Last Refreshed 13 Sep 2026, 12:00 AM
Residence Beijing, China
World Billionaires List China Billionaires Pharmaceuticals

Profile Data

Personal Stats

Age 64
Source Of Wealth Pharmaceuticals, Self Made
Residence Beijing, China
Citizenship China
Net Worth Change +$0.0B +0.0% from previous worth
Previous Net Worth $2.8B
Current Net Worth $2.8B

Worth as of May 4, 2026

About Me

Hu Kaijun is chairman and CEO of China Grand Enterprises, an investment company with interests in healthcare, real estate, agriculture and financial services. China Grand is the parent of three publicly-traded companies: Grand Pharmaceutical, Huadong Medicine (a wholesaler) and Grand Industrial Holding (a trading business). Grand Pharmaceutical agreed to buy 87.5% of U.S.-based vascular drug maker BlackSwan Vascular for $37.5 million in 2023. Hu also wholly owns Beijing Yuanda Huachuang Investment, where he also serves as chairman and CEO. Hu's wealth is derived primarily from Grand China's stakes in Huadong Medicine and Grand Pharmaceutical.

Wealth Growth

Net Worth Growth Over Time

Tracking Hu Kaijun's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth
Period Change Worth Movement
Current Net Worth: $2.8B (May 4, 2026)

© Iconic Billionaires